RT Journal Article
SR Electronic
T1 GLYCEMIC CONTROL AND PERIPHERAL ARTERIAL DISEASE IN DIABETIC FOOT PATIENTS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.01.24305179
DO 10.1101/2024.04.01.24305179
A1 Carreño, María Patricia Aragón
A1 Figueroa, Alfredo Aldama
A1 de Jesús, Fermín Rafael Martínez
A1 Cvetkovic-Vega, Aleksandar
A1 Maguiña Quispe, Jorge L.
YR 2024
UL http://medrxiv.org/content/early/2024/04/02/2024.04.01.24305179.abstract
AB Introduction Diabetic foot is a severe complication of diabetes mellitus that can cause many amputations.Objectives To evaluate the association between glycemic control and peripheral arterial disease in patients with diabetic foot.Materials and Methods An analytical cross-sectional study was performed on patients diagnosed with diabetic foot with more than ten years of evolution of diabetes mellitus who were attended in the diabetic foot outpatient clinic of the Guillermo Almenara National Hospital between June 2015 and February 2017. Glycosylated hemoglobin (HbA1C) and ankle brachial index (ABI) were used to diagnose glycemic control and peripheral arterial disease, respectively. Generalized poisson log linear regression model was used to calculate the crude (cPR) and adjusted (aPR) prevalence ratios, with 95% confidence intervals, and a significance level of p < 0.05.Results 226 patients were included in the study, finding 23% (n=52) with good glycemic control, and 44.7% (n=101) with peripheral arterial disease. The adjusted model found statistically significant associations for glycemic control, age, and sedentary lifestyle with peripheral arterial disease. Compared with patients with good glycemic control, those with poor glycemic control had a 34% higher probability to present peripheral arterial disease (aPR: 1.34, 95%CI: 1.01-1.79, p=0.045).Conclusions The prevalence of good glycemic control in the population with diabetic foot is low. Poor glycemic control was found to be independently associated with the presence of peripheral arterial disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The protocol study was approved by the Institutional Research Ethics Committee of Hospital Nacional Guillermo Almenara Yrigoyen - EsSalud, (NIT: 753-2014-1620), as well as by the Institutional Ethics Committee of the Universidad Peruana Cayetano Heredia (UPCH). (Certificate no. 141-28-14).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData file is available from this link: https://docs.google.com/spreadsheets/d/1O4n8q7s3OYyh2yjXQcVvK79HNEEErPYE/edit?usp=sharing&ouid=116904171629274874313&rtpof=true&sd=true